Protein lactate modification and Kla-modified proteins represent promising therapeutic targets for the treatment of diabetic cardiomyopathy.
Protein lactate modification (Kla) and Kla-modified proteins may serve as novel therapeutic targets for diabetic cardiomyopathy.
Absolute Event Rate: 0% vs 0%
Our findings suggest that protein lactate modification in the lactylome and proteome could be a promising treatment for DCM. This provides a reliable basis for further investigating the roles of Kla and Kla-modified proteins to develop new and effective therapeutic targets for treating DCM.
Ma et al. (Thu,) reported a other. Protein lactate modification and Kla-modified proteins represent promising therapeutic targets for the treatment of diabetic cardiomyopathy.